These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8470933)

  • 1. Immunohistochemical detection of oestrogen receptor-related protein (p29) in apocrine glands.
    Yamamura T; Honda T; Yoshikawa K; Aozasa K
    Arch Dermatol Res; 1993; 285(1-2):38-9. PubMed ID: 8470933
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of P29, an oestrogen receptor-associated tumor marker, in human term placenta.
    Cano A; Rivera J
    Placenta; 1991; 12(2):153-60. PubMed ID: 1908078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of p29, an estrogen-receptor associated tumor marker.
    Coffer AI; King RJ
    J Steroid Biochem; 1988 Nov; 31(5):745-50. PubMed ID: 3199814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.
    Ciocca DR; Luque EH
    Breast Cancer Res Treat; 1991 Dec; 20(1):33-42. PubMed ID: 1667487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
    Selim AG; Wells CA
    J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of an estrogen receptor-related protein (P29) in normal skin and in cultured human keratinocytes.
    Viac J; Su H; Réano A; Kanitakis J; Chardonnet Y; Thivolet J
    J Dermatol; 1989 Apr; 16(2):98-102. PubMed ID: 2476471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.
    Kővári B; Kocsis L; Varga E; Cserni G
    Pol J Pathol; 2018; 69(1):48-52. PubMed ID: 29895126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.
    Kővári B; Vranic S; Marchio C; Sapino A; Cserni G
    Hum Pathol; 2017 Jun; 64():164-170. PubMed ID: 28438614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.
    Robertson JF; Morris DL; Ellis IO; Armitage NC; Hardcastle JD
    Br J Cancer; 1991 Aug; 64(2):379-80. PubMed ID: 1892769
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin.
    Kanitakis J; Zambruno G; Viac J; Tommaselli L; Thivolet J
    J Cutan Pathol; 1989 Oct; 16(5):272-6. PubMed ID: 2592625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa.
    Buimer MG; Wobbes T; Klinkenbijl JH; Reijnen MM; Blokx WA
    Am J Dermatopathol; 2015 Feb; 37(2):129-32. PubMed ID: 25229569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoradiometric studies with a monoclonal antibody against an estrogen-receptor-related protein in human breast cancer.
    Cano A; Rivera J; Parrilla JJ; Abad L
    Gynecol Obstet Invest; 1988; 26(2):166-70. PubMed ID: 3220320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocrine hidrocystoma of the urethral meatus: a case report.
    Taylor D; Juhl ME; Krunic AL; Sidiropoulos M; Gerami P
    Acta Derm Venereol; 2015 Mar; 95(3):376-7. PubMed ID: 24978625
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization and biological relevance of a 29-kDa, oestrogen receptor-related protein.
    King RJ; Finley JR; Coffer AI; Millis RR; Rubens RD
    J Steroid Biochem; 1987; 27(1-3):471-5. PubMed ID: 3695491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.
    Wood A; Houghton SL; Biswas A
    Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P29, an oestrogen receptor-associated protein, is down-regulated by mifepristone in first trimester human placenta and decidua.
    Rivera J; Hill NC; López Bernal A; Mackenzie IZ; Cano A
    Hum Reprod; 1991 Oct; 6(9):1338-41. PubMed ID: 1752938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors.
    Saga K
    J Investig Dermatol Symp Proc; 2001 Nov; 6(1):49-53. PubMed ID: 11764285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.
    Marsigliante S; Greco S; Biscozzo L; Barker S; Baker V; Giuseppe L; Vinson GP; Storelli C
    Cancer Lett; 1992 Oct; 66(3):183-91. PubMed ID: 1451100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.